Category Archives: Uncategorized

22 April 2015 – ‘3Gb-TEST Central and Eastern European Regional Meeting’

On april 22nd 2015 the 3Gb-TEST Central and Eastern European Regional Meeting will be held in the Cinema Hall of the Hotel Pyramida in Prague – Czech Republic. The organization is done in collaboration with the “National coordination centre for rare diseases at University Hospital Motol”

18.15 – 21.00 (venue opens at 17.30)
Programme is available as well as a meeting report.

19 March 2015 – Regional Meeting Lund

“(WGS) NGS as tool in diagnostics”
On the 19th of March a regional meeting on whole genome sequencing; “(WGS) NGS as tool in diagnostics”, was organised at the University Hospital in Lund, Sweden. For the programme of this meeting click here. The meeting was finalized with a group discussion on a practical work flow. For an abstract on the presentations and meeting look here.


BOCCIA S., MC KEE M., ADANY R., BOFFETTA P., BURTON H., CAMBON-THOMSEN A., CORNEL M. C., GRAY M., JANI A., KNOPPERS B. M., KHOURY M. J., MESLIN E. M., VAN DUIJN C. M., VILLARI P., ZIMMERN R., CESARIO A., PUGGINA A., COLOTTO M., RICCIARDI W. Beyond Public Genomics: proposals from an International Working Group. Eur J Public Health 2014. doi: 1093/eurpub/cku142

CAMBON-THOMSEN A. Acteurs et outils de la prédiction génétique : l’éthique au cœur de la gouvernance Journal international de bioéthique et d’éthique des sciences, 2014, vol. 25, n° 2, 165-174 [following a presentation at a specialised ethics meeting in Nice, in March 2014]

3Gb-TEST meeting 7th November in Paris

7 November 2014 – Journée « NGS en diagnostic » – ‘Le NGS en pratique de diagnostic’ – French regional meeting
The French language was the main language used at a regional meeting in Paris, held on the 7th of November 2014 (Faculté de médecine de Cochin, amphithéâtre Luton, Rez-de-chaussée
24, rue du Faubourg Saint-Jacques. 75014 Paris). The title of this meeting was “Journée « NGS en diagnostic »”. More than 300 participants attended the meeting. The main topics of the meeting were the EuroGentest guidelines, quality assessment, variant analysis, bioinformatics, the selection of technologies in relation to the reimbursement system, ethics, and validation procedures. We regret that not all participants could be seated and apologize for this. Considering the large number of participants and the positive feedback, we conclude that this meeting was a real success. Programme